EcoDrugPlus

Ribosomal Protein L39

Ensembl ID : ENSATEG00000028629
Gene Symbol: RPL39
3 Cross references
288 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSATEG00000009670
Gene Symbol: RPL4
3 Cross references
340 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSATEG00000018988
Gene Symbol: RPL5
4 Cross references
452 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSATEG00000025793
Gene Symbol: RPL6
3 Cross references
487 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSATEG00000013417
Gene Symbol: RPL7
3 Cross references
492 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSATEG00000005320
Gene Symbol: RPL8
2 Cross references
277 Possible Orthologues:

Ribosomal Protein L9

Ensembl ID : ENSATEG00000019735
Gene Symbol: RPL9
1 Cross references
505 Possible Orthologues:

Ribosomal Protein S10

Ensembl ID : ENSATEG00000029580
Gene Symbol: RPS10
3 Cross references
384 Possible Orthologues:

Ribosomal Protein S11

Ensembl ID : ENSATEG00000003330
Gene Symbol: RPS11
3 Cross references
287 Possible Orthologues:

Ribosomal Protein S12

Ensembl ID : ENSATEG00000004850
Gene Symbol: RPS12
3 Cross references
401 Possible Orthologues:

Ribosomal Protein S13

Ensembl ID : ENSATEG00000000336
Gene Symbol: RPS13
3 Cross references
381 Possible Orthologues:

Ribosomal Protein S15

Ensembl ID : ENSATEG00000018167
Gene Symbol: RPS15
2 Cross references
332 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).